Investigating the anti-proliferative effect of Trypanosoma cruzi: the saga of developing concomitant immunity against cancer

Key Points

• The anti-proliferative effect of Trypanosoma cruzi may reduce cancer cell growth and spread, implying therapeutic potential.
• Analysis indicates significant immune responses observed during Trypanosoma cruzi infection, especially in cancer models.
• Study utilizes a variety of cellular assays to measure the impact of Trypanosoma cruzi on cancer proliferation rates effectively.
• Findings support the possibility of leveraging Trypanosoma cruzi to enhance immunity against cancer, warranting further exploration.